دقزامفتامین: نوسخه‌لر آراسینداکی فرق

محتوای حذف‌شده محتوای افزوده‌شده
EmausBot (دانیشیق | چالیشمالار)
ک Bot: Migrating 1 interwiki links, now provided by Wikidata on d:Q1706418
Add 1 book for verifiability (20210511)) #IABot (v2.0.8) (GreenC bot
 
خط ۲۹:
| bioavailability = Oral 75&ndash;100%<ref>{{cite encyclopedia| title=Dextromphetamine | url=http://www.drugbank.ca/drugs/DB01576#pharmacology | work=DrugBank | accessdate=5 November 2013 | section=Pharmacology }}</ref>
| protein_bound = 15–40%<ref name="Drugbank-amph" />
| metabolism = [[CYP2D6]],<ref name="FDA Pharmacokinetics" /> [[Dopamine β-hydroxylase|DBH]],<ref name="DBH ref">{{cite book | title=Foye's Principles of Medicinal Chemistry | url=https://archive.org/details/foyesprincipleso0000unse | year=2013 | publisher=Wolters Kluwer Health/Lippincott Williams & Wilkins | location=Philadelphia | isbn=1609133455 | page=[https://archive.org/details/foyesprincipleso0000unse/page/648 648] |vauthors=Lemke TL, Williams DA, Roche VF, Zito W |edition=7th | quote=Alternatively, direct oxidation of amphetamine by DA β-hydroxylase can afford norephedrine.}}</ref> [[Flavin-containing monooxygenase|FMO3]]<ref name="FMO" />
| onset = {{قیسالتما|IR|Immediate release}} dosing: 0.5-1.5&nbsp;hours<ref>{{Cite book|title = Primary Care Pediatrics|url = https://books.google.com/books?id=o43u_qWT4asC|publisher = Lippincott Williams & Wilkins|date = 2001-01-01|isbn = 9780781720083|first = Carol|last = Green-Hernandez|first2 = Joanne K.|last2 = Singleton|first3 = Daniel Z.|last3 = Aronzon|page = 243}}|quote = Table 21.2 Medications for ADHD ... D-amphetamine ... Onset: 30 min.</ref><ref>{{cite web|title = Dexedrine, ProCentra(dextroamphetamine) dosing, indications, interactions, adverse effects, and more|url = http://reference.medscape.com/drug/dexedrine-procentra-dextroamphetamine-342998#10|website = reference.medscape.com|accessdate = 2015-10-04|quote = Onset of action: 1–1.5 hr}}</ref><br />{{قیسالتما|XR|Extended release}} dosing: 1.5–2&nbsp;hours<ref name="Millichap: onset, peak, and duration">{{cite book | author = Millichap JG | editor = Millichap JG | title = Attention Deficit Hyperactivity Disorder Handbook: A Physician's Guide to ADHD | year = 2010 | publisher = Springer | location = New York, USA | isbn = 9781441913968 | page = 112 | edition = 2nd | chapter = Chapter 9: Medications for ADHD | quote = <br />Table 9.2 Dextroamphetamine formulations of stimulant medication<br />Dexedrine [Peak:2–3&nbsp;h] [Duration:5–6&nbsp;h]&nbsp;...<br />Adderall [Peak:2–3&nbsp;h] [Duration:5–7&nbsp;h]<br />Dexedrine spansules [Peak:7–8&nbsp;h] [Duration:12&nbsp;h]&nbsp;...<br />Adderall XR [Peak:7–8&nbsp;h] [Duration:12&nbsp;h]<br />Vyvanse [Peak:3–4&nbsp;h] [Duration:12&nbsp;h]}}</ref><ref name="XR onset-duration">{{cite journal | vauthors = Brams M, Mao AR, Doyle RL | title = Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder | journal = Postgrad. Med. | volume = 120 | issue = 3 | pages = 69–88 | date = September 2008 | pmid = 18824827 | doi = 10.3810/pgm.2008.09.1909 | quote = Onset of efficacy was earliest for d-MPH-ER at 0.5 hours, followed by d, l-MPH-LA at 1 to 2 hours, MCD at 1.5 hours, d, l-MPH-OR at 1 to 2 hours, MAS-XR at 1.5 to 2 hours, MTS at 2 hours, and LDX at approximately 2 hours.&nbsp;... MAS-XR, and LDX have a long duration of action at 12 hours postdose}}</ref>
| elimination_half-life = 9–11&nbsp;hours<ref name="FDA Pharmacokinetics" /><ref name="Adderall IR">{{cite web | title=Adderall IR Prescribing Information | url=http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/011522s042lbl.pdf | publisher = Teva Pharmaceuticals USA, Inc. | work = United States Food and Drug Administration | date=October 2015 | accessdate=18 May 2016 | pages=1–6}}</ref><br />[[پی‌اچ]]-dependent: 7–34&nbsp;hours<ref name="HSDB Toxnet October 2017 Full archived record" />